Hyperion Capital Advisors LP Atai Life Sciences N.V. Transaction History
Hyperion Capital Advisors LP
- $154 Million
- Q2 2025
A detailed history of Hyperion Capital Advisors LP transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Hyperion Capital Advisors LP holds 168,416 shares of ATAI stock, worth $862,289. This represents 0.24% of its overall portfolio holdings.
Number of Shares
168,416
Previous 168,416
-0.0%
Holding current value
$862,289
Previous $229,000
60.7%
% of portfolio
0.24%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
120Shares Held
31.8MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$39.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$27.8 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$17.9 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$13.5 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$6.69 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $849M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...